Changeflow GovPing Pharma & Drug Safety Metalloenzyme Inhibitor Compounds (Patent Appli...
Routine Notice Added Final

Metalloenzyme Inhibitor Compounds (Patent Application US20260097034A1)

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO published patent application US20260097034A1 for metalloenzyme inhibitor compounds. The application was filed on October 2, 2025 (Application No. 19348647) by inventors Steven Sparks, Christopher M. Yates, Sammy R. Shaver, and William J. Hoekstra. The patent covers compounds having metalloenzyme modulating activity and methods of treating diseases, disorders, or symptoms thereof mediated by such metalloenzymes.

What changed

USPTO published patent application US20260097034A1 covering metalloenzyme inhibitor compounds and methods for treating metalloenzyme-mediated diseases. The application contains CPC classifications indicating pharmaceutical compound compositions including A61K 31/501, C07D 401/14, C07D 403/04, and related therapeutic categories.

For pharmaceutical manufacturers and drug developers, this publication serves as prior art and establishes a public record of the claimed invention. Competitors conducting R&D in metalloenzyme inhibition should evaluate potential overlap with their own programs. The publication date of April 9, 2026 marks the beginning of the 18-month patent publication period, though actual patent protection would only be granted upon successful examination and issuance.

What to do next

  1. Monitor for patent grant status
  2. Review for freedom-to-operate considerations
  3. Assess competitive landscape impact

Archived snapshot

Apr 11, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METALLOENZYME INHIBITOR COMPOUNDS

Application US20260097034A1 Kind: A1 Apr 09, 2026

Inventors

Steven Sparks, Christopher M. Yates, Sammy R. Shaver, William J. Hoekstra

Abstract

Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

CPC Classifications

A61K 31/501 A61K 31/4184 A61K 31/4188 A61K 31/437 C07D 401/14 C07D 403/04 C07D 403/14 C07D 405/14 C07D 417/14 C07D 471/04

Filing Date

2025-10-02

Application No.

19348647

View original document →

Named provisions

Metalloenzyme Inhibitor Compounds

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260097034A1
Docket
19348647

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application filing Pharmaceutical compound research Drug development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Public Health Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!